Cellular Retinol-Binding Protein-1 Expression and Modulation during In Vivo and In Vitro Myofibroblastic Differentiation of Rat Hepatic Stellate Cells and Portal Fibroblasts

• Published in: Laboratory investigation Vol. 82; no. 5; pp. 619 - 628
• Main Authors: Uchio, Kozue, Tuchweber, Beatriz, Manabe, Noboru, Gabbiani, Giulio, Rosenbaum, Jean, Desmoulière, Alexis
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.05.2002; Nature Publishing; Nature Publishing Group
• Subjects: Actins - metabolism; Animals; Biological and medical sciences; Cell Differentiation; Cell Line, Transformed; Fibroblasts - drug effects; Fibroblasts - metabolism; Fibroblasts - pathology; Gastroenterology. Liver. Pancreas. Abdomen; Immunoenzyme Techniques; Kupffer Cells - drug effects; Kupffer Cells - metabolism; Kupffer Cells - pathology; Liver Cirrhosis, Experimental - etiology; Liver Cirrhosis, Experimental - metabolism; Liver Cirrhosis, Experimental - pathology; Liver. Biliary tract. Portal circulation. Exocrine pancreas; Male; Medical sciences; Other diseases. Semiology; Portal System - drug effects; Portal System - metabolism; Portal System - pathology; Rats; Rats, Sprague-Dawley; Retinol-Binding Proteins - genetics; Retinol-Binding Proteins - metabolism; Retinol-Binding Proteins, Cellular; RNA, Messenger - metabolism; Rat; Liver; Myofibroblast; Rodentia; Smooth muscle; Cell differentiation; Retinol; Kupffer cell; Binding protein; Vertebrata; Mammalia; Actin; Animal; Cellular retinol binding protein 1; Fibrosis; Fibroblast
• ISSN: 0023-6837; 1530-0307
• DOI: 10.1038/labinvest.3780456

Cellular retinol-binding protein-1 (CRBP-1) is involved in vitamin A metabolism because it mediates both retinol esterification to retinyl esters and retinol oxidation to retinal and retinoic acid. CRBP-1 is highly expressed in the liver, particularly in hepatic stellate cells (HSC). In this study, we investigated the liver expression of CRBP-1 during experimental fibrogenesis. We also studied the regulation of CRBP-1 expression in cultured HSC and portal fibroblasts, two fibroblastic cell types involved in liver fibrogenesis. Fibrosis was induced in rats by carbon tetrachloride (CCl4) or bile duct ligation. Immunohistochemical staining was performed for CRBP-1 and α-smooth muscle (SM) actin, an activation marker of fibrogenic cells. CRBP-1 and α-SM actin expression was studied by Western blotting and/or Northern blot in primary cultures of HSC isolated by conventional methods and in portal fibroblasts that were obtained by outgrowth from the biliary tree after enzymatic digestion. In normal liver, contrary to HSC, portal fibroblasts did not express CRBP-1. After CCl4 injury, CRBP-1 expression was maintained in myofibroblastic α-SM actin-positive HSC. After bile duct ligation, portal fibroblasts (which proliferated around ductular structures) acquired expression of both CRBP-1 and α-SM actin. During HSC activation in culture, CRBP-1 expression gradually increased until Day 5 when α-SM actin expression was obvious. Cultured portal fibroblasts developed both CRBP-1 and α-SM actin expression. In both cell populations, transforming growth factor-β1 treatment increased CRBP-1 expression. Thus, in normal liver, CRBP-1 expression was different among fibroblastic cells, a finding that adds to the concept of heterogeneity of liver fibrogenic cells. Furthermore, during myofibroblastic differentiation, HSC that lost their stores of retinol maintained a high level of CRBP-1 expression, whereas portal fibroblasts acquired CRBP1 expression. Together, these data suggest a correlation between CRBP-1 expression and myofibroblastic differentiation.